Request Demo
Last update 04 Jun 2026
Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.
Last update 04 Jun 2026
Overview
Tags
Other Diseases
Growth factors
Disease domain score
A glimpse into the focused therapeutic areas
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20211688
阿莫西林克拉维酸钾片随机、开放、单剂量、两制剂、交叉对照设计在中国健康受试者中的生物等效性正式试验
[Translation] A formal bioequivalence study of amoxicillin and clavulanate potassium tablets in Chinese healthy volunteers using a randomized, open-label, single-dose, two-formulation, crossover controlled design
ChiCTR2100046979
A randomized, open label, single-dose, two-treatment, two-sequence, three-period, crossover pharmacokinetic study of Amoxicillin and Clavulanate Potassium Tablets in Chinese healthy subjects under fasting and fed condition
100 Clinical Results associated with Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.
Login to view more data
100 Translational Medicine associated with Hangzhou Tian-Mu-Shan Pharmaceutical Enterprise Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 25 Aug 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free